Cargando…

What Determines Spontaneous Physical Activity in Patients with Parkinson’s Disease?

Physical activity (PA) is a factor that may have an influence on the symptoms of Parkinson’s disease (PD). The aim of this study was to identify the potential determinants of spontaneous PA in a PD patient group. A total of 134 PD patients aged 65.2 ± 9.2 years with a Hoehn–Yahr scale score ≤4 and a...

Descripción completa

Detalles Bibliográficos
Autores principales: Gorzkowska, Agnieszka, Cholewa, Joanna, Małecki, Andrzej, Klimkowicz-Mrowiec, Aleksandra, Cholewa, Jarosław
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288325/
https://www.ncbi.nlm.nih.gov/pubmed/32369962
http://dx.doi.org/10.3390/jcm9051296
_version_ 1783545253223989248
author Gorzkowska, Agnieszka
Cholewa, Joanna
Małecki, Andrzej
Klimkowicz-Mrowiec, Aleksandra
Cholewa, Jarosław
author_facet Gorzkowska, Agnieszka
Cholewa, Joanna
Małecki, Andrzej
Klimkowicz-Mrowiec, Aleksandra
Cholewa, Jarosław
author_sort Gorzkowska, Agnieszka
collection PubMed
description Physical activity (PA) is a factor that may have an influence on the symptoms of Parkinson’s disease (PD). The aim of this study was to identify the potential determinants of spontaneous PA in a PD patient group. A total of 134 PD patients aged 65.2 ± 9.2 years with a Hoehn–Yahr scale score ≤4 and a Mini Mental State Examination (MMSE) score ≥24 were examined. For the study’s purposes, the authors analyzed age, sex, education, history of PD, dopaminergic treatment, the severity of PD symptoms using Unified Parkinson’s Disease Rating Scale (UPDRS), and Hoehn–Yahr scale. Additionally, all participants were evaluated through a set of scales for specific neuropsychiatric symptoms including depression, anxiety, apathy, fatigue, and sleep disorders. A linear regression analysis was used with backward elimination. In the total explanatory model, for 12% of the variability in activity (R(2) = 0.125; F(16.133) = 2.185; p < 0.01), the significant predictor was starting therapy with the dopamine agonist (DA) (β= 0.420; t= 4.068; p = 0.000), which was associated with a longer duration of moderate PA. In the total explanatory model, for more than 13% of the variance in time spent sitting (R(2) = 0.135; F(16.130) = 2.267; p < 0.01), the significant predictors were secondary education and the results of the UPDRS. The patients with secondary and vocational education, those starting treatment with DA and those with a less severe degree of Parkinson’s symptoms (UPDRS), spent less time sitting in a day. It is possible to identify determinants of spontaneous PA. It may elucidate consequences in terms of influence on modifiable conditions of PA and the proper approach to patients with unmodifiable PA factors.
format Online
Article
Text
id pubmed-7288325
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-72883252020-06-17 What Determines Spontaneous Physical Activity in Patients with Parkinson’s Disease? Gorzkowska, Agnieszka Cholewa, Joanna Małecki, Andrzej Klimkowicz-Mrowiec, Aleksandra Cholewa, Jarosław J Clin Med Article Physical activity (PA) is a factor that may have an influence on the symptoms of Parkinson’s disease (PD). The aim of this study was to identify the potential determinants of spontaneous PA in a PD patient group. A total of 134 PD patients aged 65.2 ± 9.2 years with a Hoehn–Yahr scale score ≤4 and a Mini Mental State Examination (MMSE) score ≥24 were examined. For the study’s purposes, the authors analyzed age, sex, education, history of PD, dopaminergic treatment, the severity of PD symptoms using Unified Parkinson’s Disease Rating Scale (UPDRS), and Hoehn–Yahr scale. Additionally, all participants were evaluated through a set of scales for specific neuropsychiatric symptoms including depression, anxiety, apathy, fatigue, and sleep disorders. A linear regression analysis was used with backward elimination. In the total explanatory model, for 12% of the variability in activity (R(2) = 0.125; F(16.133) = 2.185; p < 0.01), the significant predictor was starting therapy with the dopamine agonist (DA) (β= 0.420; t= 4.068; p = 0.000), which was associated with a longer duration of moderate PA. In the total explanatory model, for more than 13% of the variance in time spent sitting (R(2) = 0.135; F(16.130) = 2.267; p < 0.01), the significant predictors were secondary education and the results of the UPDRS. The patients with secondary and vocational education, those starting treatment with DA and those with a less severe degree of Parkinson’s symptoms (UPDRS), spent less time sitting in a day. It is possible to identify determinants of spontaneous PA. It may elucidate consequences in terms of influence on modifiable conditions of PA and the proper approach to patients with unmodifiable PA factors. MDPI 2020-05-01 /pmc/articles/PMC7288325/ /pubmed/32369962 http://dx.doi.org/10.3390/jcm9051296 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Gorzkowska, Agnieszka
Cholewa, Joanna
Małecki, Andrzej
Klimkowicz-Mrowiec, Aleksandra
Cholewa, Jarosław
What Determines Spontaneous Physical Activity in Patients with Parkinson’s Disease?
title What Determines Spontaneous Physical Activity in Patients with Parkinson’s Disease?
title_full What Determines Spontaneous Physical Activity in Patients with Parkinson’s Disease?
title_fullStr What Determines Spontaneous Physical Activity in Patients with Parkinson’s Disease?
title_full_unstemmed What Determines Spontaneous Physical Activity in Patients with Parkinson’s Disease?
title_short What Determines Spontaneous Physical Activity in Patients with Parkinson’s Disease?
title_sort what determines spontaneous physical activity in patients with parkinson’s disease?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288325/
https://www.ncbi.nlm.nih.gov/pubmed/32369962
http://dx.doi.org/10.3390/jcm9051296
work_keys_str_mv AT gorzkowskaagnieszka whatdeterminesspontaneousphysicalactivityinpatientswithparkinsonsdisease
AT cholewajoanna whatdeterminesspontaneousphysicalactivityinpatientswithparkinsonsdisease
AT małeckiandrzej whatdeterminesspontaneousphysicalactivityinpatientswithparkinsonsdisease
AT klimkowiczmrowiecaleksandra whatdeterminesspontaneousphysicalactivityinpatientswithparkinsonsdisease
AT cholewajarosław whatdeterminesspontaneousphysicalactivityinpatientswithparkinsonsdisease